PER 13.0% 13.0¢ percheron therapeutics limited

Ann: Funding for ATL1103 Phase II Trial and Pipel, page-16

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,102 Posts.
    lightbulb Created with Sketch. 386
    re: Ann: Funding for ATL1103 Phase II Trial a... One just needs to compare and see value -

    PRR ,MC $220m and lets see what u get -




    Now ANP ,MC under $20m -




    Does that make us a 11 bagger ?




 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.